VYR-206 | m-entrepreneurship.com

Product Name :
VYR-206

Search keywords :
Neurokinin B

drugId :
null

Target Vo:
Cannabinoid CB1 receptor

Target Vo Short Name :
CB1

Moa_Name:
Cannabinoid CB1 receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
National Yang-Ming University, Kaohsiung, Taiwan, Roc

Active Company_Name :
National Yang-Ming University, Kaohsiung, Taiwan, Roc

Active Indication_Name:
Plasmablastic Lymphoma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CDK9 Rabbit mAb Purity
PAX6 Antibody In Vivo
eIF4B Antibody: eIF4B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to eIF4B. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts